XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Total
Previously Reported
Revision of Prior Period, Adjustment
Preferred Stock
Preferred Stock
Previously Reported
Preferred Stock
Revision of Prior Period, Adjustment
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Previously Reported
Common Stock
Class A Common Stock
Revision of Prior Period, Adjustment
Common Stock
Class C Common Stock
Common Stock
Class C Common Stock
Previously Reported
Common Stock
Class C Common Stock
Revision of Prior Period, Adjustment
Additional Paid-In Capital
Additional Paid-In Capital
Previously Reported
Additional Paid-In Capital
Revision of Prior Period, Adjustment
Subscription Receivable
Subscription Receivable
Previously Reported
Subscription Receivable
Revision of Prior Period, Adjustment
Accumulated Deficit
Accumulated Deficit
Previously Reported
Accumulated Deficit
Revision of Prior Period, Adjustment
Beginning balance (in shares) at Dec. 31, 2022       0 0 0 11,806,007 771,155 11,034,852 3,213,678 0 3,213,678                  
Beginning balance at Dec. 31, 2022 $ 3,401,413 $ 3,401,413 $ 0 $ 0 $ 0 $ 0 $ 1,181 $ 771 $ 410 $ 321 $ 0 $ 321 $ 12,383,475 $ 12,384,206 $ (731) $ (99,612) $ (99,612) $ 0 $ (8,883,952) $ (8,883,952) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Conversion of notes to common stock 2,050,000                                        
Issuance of common stock for cash (in shares)             1,447,523                            
Issuance of common stock for cash 2,500,124           $ 145           2,499,979                
Receipt of subscription (receivable) payable 100,012                             100,012          
Issuance of common stock for asset acquisition (in shares)             1,071,229                            
Issuance of common stock for asset acquisition 1,334,858           $ 107           1,334,751                
Net loss (6,687,640)                                   (6,687,640)    
Ending balance at Mar. 31, 2023 648,767     $ 0     $ 1,433     $ 321     16,218,205     400     (15,571,592)    
Ending balance (in shares) at Mar. 31, 2023       0     14,324,759     3,213,678                      
Beginning balance (in shares) at Dec. 31, 2022       0 0 0 11,806,007 771,155 11,034,852 3,213,678 0 3,213,678                  
Beginning balance at Dec. 31, 2022 3,401,413 3,401,413 0 $ 0 $ 0 $ 0 $ 1,181 $ 771 $ 410 $ 321 $ 0 $ 321 12,383,475 12,384,206 (731) (99,612) (99,612) 0 (8,883,952) (8,883,952) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Net loss (47,647,611)                                        
Ending balance at Sep. 30, 2023 11,505,088     $ 0     $ 2,434     $ 321     68,033,896     0     (56,531,563)    
Ending balance (in shares) at Sep. 30, 2023       0     24,340,075     3,213,678                      
Beginning balance (in shares) at Dec. 31, 2022       0 0 0 11,806,007 771,155 11,034,852 3,213,678 0 3,213,678                  
Beginning balance at Dec. 31, 2022 3,401,413 $ 3,401,413 $ 0 $ 0 $ 0 $ 0 $ 1,181 $ 771 $ 410 $ 321 $ 0 $ 321 12,383,475 $ 12,384,206 $ (731) (99,612) $ (99,612) $ 0 (8,883,952) $ (8,883,952) $ 0
Ending balance at Dec. 31, 2023 10,434,042     $ 0     $ 2,441     $ 321     72,644,419     0     (62,213,139)    
Ending balance (in shares) at Dec. 31, 2023       0     24,410,075     3,213,678                      
Beginning balance (in shares) at Mar. 31, 2023       0     14,324,759     3,213,678                      
Beginning balance at Mar. 31, 2023 648,767     $ 0     $ 1,433     $ 321     16,218,205     400     (15,571,592)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Conversion of notes to common stock 20,450,000                                        
Receipt of subscription (receivable) payable (400)                             (400)          
Net loss (20,721,307)                                   (20,721,307)    
Ending balance at Jun. 30, 2023 (20,072,940)     $ 0     $ 1,433     $ 321     16,218,205     0     (36,292,899)    
Ending balance (in shares) at Jun. 30, 2023       0     14,324,759     3,213,678                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Conversion of notes to common stock (in shares)             3,984,388                            
Conversion of notes to common stock 37,294,023           $ 397           37,293,626                
Issuance of common stock for Credova Merger (in shares)             7,735,151                            
Issuance of common stock for Credova Merger 12,426,780           $ 774           12,426,006                
Forfeiture of shares (in shares)             (1,704,223)                            
Forfeiture of shares 0           $ (170)           170                
Share-based compensation 2,095,889                       2,095,889                
Net loss (20,238,664)                                   (20,238,664)    
Ending balance at Sep. 30, 2023 11,505,088     $ 0     $ 2,434     $ 321     68,033,896     0     (56,531,563)    
Ending balance (in shares) at Sep. 30, 2023       0     24,340,075     3,213,678                      
Beginning balance (in shares) at Dec. 31, 2023       0     24,410,075     3,213,678                      
Beginning balance at Dec. 31, 2023 10,434,042     $ 0     $ 2,441     $ 321     72,644,419     0     (62,213,139)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Issuance of common stock for Credova Merger (in shares)             2,920,993                            
Issuance of common stock for Credova Merger 14,137,606           $ 292           14,137,314                
Issuance of shares for consulting arrangement (in shares)             183,349                            
Issuance of shares for consulting arrangement 887,409           $ 18           887,391                
Issuance of shares for fully vested restricted stock units (in shares)             663,500                            
Issuance of shares for fully vested restricted stock units 0           $ 66           (66)                
Share-based compensation 5,410,894                       5,410,894                
Net loss (12,576,831)                                   (12,576,831)    
Ending balance at Mar. 31, 2024 18,293,120     $ 0     $ 2,817     $ 321     93,079,952     0     (74,789,970)    
Ending balance (in shares) at Mar. 31, 2024       0     28,177,917     3,213,678                      
Beginning balance (in shares) at Dec. 31, 2023       0     24,410,075     3,213,678                      
Beginning balance at Dec. 31, 2023 10,434,042     $ 0     $ 2,441     $ 321     72,644,419     0     (62,213,139)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Net loss (36,949,626)                                        
Ending balance at Sep. 30, 2024 4,403,005     $ 0     $ 2,945     $ 321     103,562,504     0     (99,162,765)    
Ending balance (in shares) at Sep. 30, 2024       0     29,451,684     3,213,678                      
Beginning balance (in shares) at Mar. 31, 2024       0     28,177,917     3,213,678                      
Beginning balance at Mar. 31, 2024 18,293,120     $ 0     $ 2,817     $ 321     93,079,952     0     (74,789,970)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Share-based compensation 5,171,761                       5,171,761                
Net loss (11,235,246)                                   (11,235,246)    
Ending balance at Jun. 30, 2024 12,229,635     $ 0     $ 2,817     $ 321     98,251,713     0     (86,025,216)    
Ending balance (in shares) at Jun. 30, 2024       0     28,177,917     3,213,678                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Issuance of shares for fully vested restricted stock units (in shares)             1,273,767                            
Issuance of shares for fully vested restricted stock units (485,904)           $ 128           (486,032)                
Share-based compensation 5,796,823                       5,796,823                
Net loss (13,137,549)                                   (13,137,549)    
Ending balance at Sep. 30, 2024 $ 4,403,005     $ 0     $ 2,945     $ 321     $ 103,562,504     $ 0     $ (99,162,765)    
Ending balance (in shares) at Sep. 30, 2024       0     29,451,684     3,213,678